1. |
|
2. |
|
3. |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
|
4. |
|
5. |
|
6. |
|
7. |
|
8. |
|
9. |
|
10. |
|
11. |
|
12. |
|
13. |
|
14. |
|
15. |
|
16. |
|
17. |
|
18. |
|
19. |
|
20. |
|
21. |
|
22. |
|
23. |
|
24. |
|
25. |
|
26. |
|
27. |
|
28. |
Ruiz A, Flores-Gonzalez J, Buendia-Roldan I, et al. Telomere Shortening and Its Association with Cell Dysfunction in Lung Diseases[J]. Int J Mol Sci, 2021, 23(1).
|
29. |
|
30. |
|
31. |
|
32. |
|
33. |
|
34. |
Whiteside S A, McGinniss J E, Collman R G. The lung microbiome: progress and promise[J]. J Clin Invest, 2021, 131(15).
|
35. |
|
36. |
|
37. |
|